Provided by Tiger Fintech (Singapore) Pte. Ltd.

NeuroPace Inc.

8.97
+0.32003.70%
Volume:157.62K
Turnover:1.40M
Market Cap:296.74M
PE:-10.69
High:8.99
Open:8.65
Low:8.61
Close:8.65
52wk High:18.98
52wk Low:5.45
Shares:33.08M
Float Shares:22.52M
Volume Ratio:0.65
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8387
EPS(LYR):-0.9318
ROE:-176.94%
ROA:-12.39%
PB:15.27
PE(LYR):-9.63

Loading ...

BRIEF-Neuropace Inc Maintaining 2025 Revenue Guidance

Reuters
·
Apr 03

NeuroPace to terminate distribution relationship for Seeg products

TIPRANKS
·
Apr 03

NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire
·
Mar 26

NeuroPace, Inc. (NASDAQ:NPCE) Annual Results: Here's What Analysts Are Forecasting For This Year

Simply Wall St.
·
Mar 07

NeuroPace Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.
·
Mar 06

NeuroPace Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Mar 06

Q4 2024 Neuropace Inc Earnings Call

Thomson Reuters StreetEvents
·
Mar 05

NeuroPace Inc (NPCE) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

GuruFocus.com
·
Mar 05

Neuropace Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 05

BRIEF-NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results

Reuters
·
Mar 05

NeuroPace Inc.: Q4 Earnings Snapshot

Associated Press Finance
·
Mar 05

NeuroPace Q4 EPS $(0.18) Beats $(0.22) Estimate, Sales $21.47M Beat $21.17M Estimate

Benzinga
·
Mar 05

NeuroPace to Present at the Leerink Partners Global Healthcare Conference

GlobeNewswire
·
Mar 04

Lake Street Reaffirms Their Buy Rating on NeuroPace (NPCE)

TIPRANKS
·
Mar 03

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 03

Neuropace Inc expected to post a loss of 22 cents a share - Earnings Preview

Reuters
·
Mar 01

NeuroPace (NPCE) Surges 5.8%: Is This an Indication of Further Gains?

Zacks
·
Feb 21

NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

GlobeNewswire
·
Feb 20

NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire
·
Feb 19